Accelerated cardiovascular risk after viral clearance in hepatitis C patients with the NAMPT-rs61330082 TT genotype: An 8-year prospective cohort study

Involvement of extracellular nicotinamide phosphoribosyltransferase (eNAMPT, i.e., visfatin or pre-B-cell colony-enhancing factor), a cancer metabokine, in chronically hepatitis C virus (HCV)-infected (CHC) patients with sustained virological responses (SVRs) remains elusive. This 8-year prospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Ming-Ling, Lin, Yu-Sheng, Chang, Ming-Yu, Hsu, Chia-Lin, Chien, Rong-Nan, Fann, Cathy SJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834047/
https://www.ncbi.nlm.nih.gov/pubmed/33446046
http://dx.doi.org/10.1080/21505594.2020.1870080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834047/
https://www.ncbi.nlm.nih.gov/pubmed/33446046
http://dx.doi.org/10.1080/21505594.2020.1870080

Ejemplares similares